Publicacions en col·laboració amb investigadors/es de Hospital Universitario Virgen de las Nieves (15)

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

2022

  1. Novel genes and sex differences in COVID-19 severity

    Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806

2019

  1. Clinical and molecular diagnosis of non-phosphomannomutase 2 N-linked congenital disorders of glycosylation in Spain

    Clinical Genetics, Vol. 95, Núm. 5, pp. 615-626

2015

  1. Clinical and genetic features of Spanish patients with Mevalonate kinase deficiency

    Pediatric Rheumatology, Vol. 13, Núm. 1

2014

  1. Improving patient safety by detecting obstetric care-related adverse events: Application of a new screening guide

    Archives of Gynecology and Obstetrics, Vol. 289, Núm. 5, pp. 945-952

  2. Predictive factors of severe multilobar pneumonia and shock in patients with influenza

    Emergency Medicine Journal, Vol. 31, Núm. 4, pp. 301-307

2013

  1. Risk factors and effectiveness of preventive measures against influenza in the community

    Influenza and other Respiratory Viruses, Vol. 7, Núm. 2, pp. 177-183

2012

  1. Effectiveness of hand hygiene and provision of information in preventing influenza cases requiring hospitalization

    Preventive Medicine, Vol. 54, Núm. 6, pp. 434-439

  2. Prognosis of hospitalized patients with 2009 H1N1 influenza in Spain: Influence of neuraminidase inhibitors

    Journal of Antimicrobial Chemotherapy, Vol. 67, Núm. 7, pp. 1739-1745

2011

  1. Genotype-phenotype correlations in sepiapterin reductase deficiency. A splicing defect accounts for a new phenotypic variant

    Neurogenetics, Vol. 12, Núm. 3, pp. 183-191

2008

  1. Efficacy of pegylated interferon plus ribavirin treatment in HIV/ hepatitis C virus co-infected patients receiving abacavir plus lamivudine or tenofovir plus either lamivudine or emtricitabine as nucleoside analogue backbone

    Journal of Antimicrobial Chemotherapy, Vol. 62, Núm. 6, pp. 1365-1373

  2. Low rate of adverse hepatic events associated with fosamprenavir/ritonavir-based antiretroviral regimens

    HIV Clinical Trials, Vol. 9, Núm. 5, pp. 309-313

2007

  1. Is natural conception a valid option for HIV-serodiscordant couples?

    Human Reproduction, Vol. 22, Núm. 9, pp. 2353-2358

2005

  1. Resistance to nonnucleoside reverse-transcriptase inhibitors and prevalence of HIV type 1 non-B subtypes are increasing among persons with recent infection in Spain

    Clinical Infectious Diseases, Vol. 41, Núm. 9, pp. 1350-1354

2004

  1. Efectos adversos en la asistencia hospitalaria. Una revisión crítica

    Medicina Clinica, Vol. 123, Núm. 1, pp. 21-25